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Manipulation of Genome Integrity Signaling Axes Contributing to Prostate Cancer
Aggressiveness
Frank Duan, Dr. Veronica Rodriguez-Bravo*
Introduction: Prostate cancer (PC) is one of the leading causes of death in men, and
despite current treatment options patients can develop aggressive disease that spreads
to other parts of the body. Little research has focused to date on the effect of
centrosome biology in the pathogenesis of PC.
Methods: Two metastatic PC cell lines, DU145 and 22Rv1, as well as highly aggressive
derivatives generated in Dr. Rodriguez-Bravo lab (docetaxel-resistant; (DR) variants)
were compared through various experiments to determine differences in centrosome
proteins expression and functionality. All cells (DU145 /DR and 22Rv1 /DR) underwent
electroporations with siRNAs to knockout one of the centrosomal target genes (STIL)
and were compared to siRNA controls (not targeting any human gene). Subsequently,
western blots, RT-PCRs, colony formation assays, and immunofluorescence
microscopy were used to analyze the differences between controls and STIL
knockdowns and between different cell lines.
Results: Analysis of the experiments performed suggest that there is a greater effect of
the STIL knockdown than the siRNA control in decreasing cell proliferation in PC cells.
There was also insufficient evidence to determine if there was a difference between the
parental and DR cells.
Discussion: There was statistically significant evidence that knockout of STIL
decreased cell proliferation of metastatic PC cells DU154 and 22Rv1. This suggests a
potential role between centrosome regulating mechanisms and the aggressiveness of

PC cells. Future research could aim to determine the extent of the effect of the
knockdown and potentially be exploited in the future of treatments for late-stage PC.

